Related Experiment Video
Updated: Oct 12, 2025
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
566
Current interventional therapies in acute pulmonary embolism
Alisha Jamil1, Hillary Johnston-Cox2, Steven Pugliese3
1Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, United States of America.
Progress in Cardiovascular Diseases
|November 25, 2021
Summary
Pulmonary embolism (PE) management is advancing with new technologies and team-based care. This review covers PE risk stratification, interventional therapies, clinical endpoints, and mechanical circulatory support for complex cases.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Interventional Radiology
Background:
- Pulmonary embolism (PE) ranks as the third primary cause of cardiovascular mortality.
- Current PE management strategies are evolving due to technological advancements and integrated care models.
Purpose of the Study:
- To provide an overview of current Pulmonary Embolism management.
- To focus on risk stratification, interventional therapies, clinical endpoints, and mechanical circulatory support in PE treatment.
Main Methods:
- Review of current literature and clinical guidelines on Pulmonary Embolism.
- Analysis of emerging technologies and team-based approaches in PE care.
- Evaluation of clinical endpoints for assessing interventional therapy effectiveness.
Main Results:
- Risk stratification is crucial for tailoring PE treatment strategies.
- Interventional therapies are increasingly utilized for specific PE patient populations.
- Mechanical circulatory support plays a role in managing complex and severe PE cases.
Conclusions:
- The evolving landscape of Pulmonary Embolism necessitates a comprehensive approach.
- Integrating risk stratification, advanced therapies, and defined endpoints optimizes patient outcomes.
- Mechanical circulatory support offers a vital option for refractory PE.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
68
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
68
01:27Pulmonary Embolism III: Nursing Management
72
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
72
01:29Venous Thrombosis III: Interprofessional Care
57
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
57
01:29Pulmonary Embolism I: Introduction
177
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
177
01:27Peripheral Artery Disease III: Interprofessional Care
52
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
52
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
274
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
274